NPSP Financial Facts
Cost of royalties: 0Interest income, net: 70K
See Full Income Statement
Total stockholders' deficit: -38.56M
Goodwill: 9.43M
See Full Balance Sheet
NPS Pharmaceuticals, Inc. (NPSP) Earnings
|
Expand Research on NPSP
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -158.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.2% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
2/18/15  |
Q414 | -$0.02 | $0.06 | -$0.08 | $66.7M | $69.3M | N/A |  | | Details | |
| 11/10/14 |
 |
Q314 | -$0.02 | $0.01 | -$0.03 | $57.2M | $59.5M | N/A | | | Details |
| 8/6/14 |
|
Q214 | $0.02 | $0.00 | +$0.02 | $56.13M | $53.06M | N/A | | | Details |
| 5/8/14 |
|
Q114 | -$0.06 | -$0.02 | -$0.04 | $44.04M | $48.3M | N/A | | | Details |
| 2/18/14 |
|
Q413 | $0.07 | $0.02 | +$0.05 | $54.45M | $44.22M | N/A | | | Details |
| 11/6/13 |
|
Q313 | -$0.01 | -$0.02 | +$0.01 | $39.2M | $38.4M | N/A | | | Details |
| 8/8/13 |
|
Q213 | -$0.13 | -$0.07 | -$0.06 | $36.5M | $31.62M | N/A | | | Details |
| 5/9/13 |
|
Q113 | -$0.09 | -$0.13 | +$0.04 | $25.43M | $27.56M | N/A | | | Details |
